Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 991 M1.04 B1.03 B1.19 B1.01 B1.05 B 4.29 B Research & development —————— — Operating income 1.53 B1.5 B1.52 B1.51 B1.49 B1.43 B 5.95 B Non-Operating Income, Total 73 M25 M13 M116 M-95 M117 M 151 M Interest expense, net of interest capitalized 103 M114 M113 M111 M111 M126 M 461 M Non-Operating Income, excl. Interest Expenses 90 M32 M16 M100 M-105 M-30 M -19 M Unusual income/expense -17 M-7 M-3 M16 M10 M21 M 44 M Pretax income 1.5 B1.42 B1.42 B6.29 B1.28 B1.42 B 10.41 B Equity in earnings —————— — Taxes 316 M268 M285 M190 M280 M206 M 961 M Non-controlling/minority interest —————— — After tax other income/expense 73 M224 M-52 M42 M-70 M— — Net income before discontinued operations 1.29 B1.26 B1.25 B1.44 B1.11 B1.1 B 4.9 B Discontinued operations —————— — Net income 1.29 B1.26 B1.25 B1.44 B1.11 B1.1 B 4.9 B Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders 1.29 B1.26 B1.25 B1.44 B1.11 B1.1 B 4.9 B Basic earnings per share (Basic EPS) 1.311.31.311.541.221.26 5.33 Diluted earnings per share (Diluted EPS) 1.291.291.31.531.211.25 5.29 Average basic shares outstanding 986 M969 M950 M959 M913 M895 M — Diluted shares outstanding 999 M977 M960 M968 M920 M901 M — EBITDA 1.77 B1.74 B1.76 B1.75 B1.73 B1.5 B 6.73 B EBIT 1.53 B1.5 B1.52 B1.51 B1.49 B1.43 B 5.95 B Cost of revenue —————— — Other cost of goods sold —————— — Depreciation & amortization (cash flow) 245 M239 M245 M234 M238 M69 M 786 M